Results were not as wonderful as some had hoped.
Nevertheless, a lack of side-effects is confirmed and there is enough meat in the results to expect that commercial success could eventually materialise for Viraleze.
However, this is still SPL. (e.g. The ridiculously long delay while the data was being "cleaned".) My opinion of SPL now? Let's see how SPL follows this up. Acceptance by TGA? FDA? New deals? Substantial revenue? More studies? It seems to still be a gamble. I doubt if SPL has what it takes. But at least it now appears more certain that Viraleze is a product that a more competent pharma could market successfully. So, a takeover becomes a more realistic possibility.
Results were not as wonderful as some had hoped.Nevertheless, a...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $12.03K | 116.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 109616 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |